Functional, Global and Cognitive Decline Correlates to Accumulation of Alzheimers Pathology in MCI and AD

Diagnostic and Statistical Manual of Mental Disorders

Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,841 · see citing works

“Mini-mental state”

Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282 · see citing works

Clinical diagnosis of Alzheimer's disease: Report of the NINCDS‐ADRDA Work Group* under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915 · see citing works

Neuropathological stageing of Alzheimer-related changes.

Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123 · see citing works

Mild Cognitive Impairment: Clinical Characterization and Outcome

Petersen, R. C., Smith, G. E., Waring, S. C., Ivnik, R. J., Tangalos, E. G., & Kokmen, E. (1999) · Archives of Neurology · doi:10.1001/archneur.56.3.303 · Cited by 8,980 · see citing works

The Global Deterioration Scale for assessment of primary degenerative dementia

Reisberg, ‌., Ferris, S. H., de Leon, M. J., & Crook, T. H. (1982) · American Journal of Psychiatry · doi:10.1176/ajp.139.9.1136 · Cited by 4,982 · see citing works

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD): Part II. Standardization of the neuropathologic assessment of Alzheimer's disease

Mirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961 · see citing works

Vascular dementia: Diagnostic criteria for research studies: Report of the NINDS‐AIREN International Workshop*

Román, G. C., Tatemichi, T. K., Erkinjuntti, T., Cummings, J. L., Masdeu, J. C., Garcia, J. H., Amaducci, L., Orgogozo, J.-M., Brun, A., Hofman, A., et al. (1993) · Neurology · doi:10.1212/wnl.43.2.250 · Cited by 4,921 · see citing works

Current concepts in mild cognitive impairment

Petersen, R. C., Doody, R., Kurz, A., Mohs, R. C., Morris, J. C., Rabins, P. V., Ritchie, K., Rossor, M., Thal, L., & Winblad, B. (2001) · Archives of Neurology · doi:10.1001/archneur.58.12.1985 · Cited by 4,781 · see citing works

Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment

Terry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397 · see citing works

The Association Between Quantitative Measures of Dementia and of Senile Change in the Cerebral Grey Matter of Elderly Subjects

Blessed, G., Tomlinson, B. E., & Roth, M. (1968) · British Journal of Psychiatry · doi:10.1192/bjp.114.512.797 · Cited by 4,117 · see citing works

Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshop

McKeith, I. G., Galasko, D., Kosaka, K., Perry, E. K., Dickson, D. W., Hansen, L. A., Salmon, D. P., Lowe, J., Mirra, S. S., Byrne, E. J., et al. (1996) · Neurology · doi:10.1212/wnl.47.5.1113 · Cited by 3,960 · see citing works

Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease

Arriagada, P. V., Growdon, J. H., Hedley-Whyte, E. T., & Hyman, B. T. (1992) · Neurology · doi:10.1212/wnl.42.3.631 · Cited by 2,668 · see citing works

Diagnosis of Alzheimer's Disease

Khachaturian, Z. S. (1985) · Archives of Neurology · doi:10.1001/archneur.1985.04060100083029 · Cited by 2,499 · see citing works

Profound Loss of Layer II Entorhinal Cortex Neurons Occurs in Very Mild Alzheimer’s Disease

Gómez-Isla, T., Price, J. L., McKeel Jr., D. W., Morris, J. C., Growdon, J. H., & Hyman, B. T. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-14-04491.1996 · Cited by 1,796 · see citing works

Long-term effects of Aβ42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial

Holmes, C., Boche, D., Wilkinson, D., Yadegarfar, G., Hopkins, V., Bayer, A., Jones, R. W., Bullock, R., Love, S., Neal, J. W., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61075-2 · Cited by 1,416 · see citing works

Correlation Between Elevated Levels of Amyloid β-Peptide in the Brain and Cognitive Decline

Näslund, J. (2000) · JAMA · doi:10.1001/jama.283.12.1571 · Cited by 1,268 · see citing works

Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer’s disease

Giannakopoulos, P., Herrmann, F. R., Bussière, T., Bouras, C., Kövari, E., Perl, D. P., Morrison, J. H., Gold, G., & Hof, P. R. (2003) · Neurology · doi:10.1212/01.wnl.0000063311.58879.01 · Cited by 1,118 · see citing works

Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration

Cairns, N. J., Bigio, E. H., Mackenzie, I. R. A., Neumann, M., Lee, V. M.-Y., Hatanpaa, K. J., White, C. L., Schneider, J. A., Grinberg, L. T., Halliday, G., et al. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0237-2 · Cited by 1,110 · see citing works

Functional Assessment Staging (FAST)

Gauthier, S. G. (2001) · CRC Press eBooks · doi:10.3109/9780203213896-33 · Cited by 1,023 · see citing works

The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer's disease

Price, J. L., Davis, P. B., Morris, J. C., & White, D. L. (1991) · Neurobiology of Aging · doi:10.1016/0197-4580(91)90006-6 · Cited by 818 · see citing works

Dementia associated with Parkinson's disease

Emre, M. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00351-x · Cited by 686 · see citing works

Early Aβ accumulation and progressive synaptic loss, gliosis, and tangle formation in AD brain

Ingelsson, M., Fukumoto, H., Newell, K. L., Growdon, J. H., Hedley–Whyte, E. T., Frosch, M. P., Albert, M. S., Hyman, B. T., & Irizarry, M. C. (2004) · Neurology · doi:10.1212/01.wnl.0000115115.98960.37 · Cited by 666 · see citing works

Clinicopathologic Studies in Cognitively Healthy Aging and Alzheimer Disease: Relation of Histologic Markers to Dementia Severity, Age, Sex, and Apolipoprotein E Genotype

Berg, L., McKeel, D. W., Miller, J. P., Storandt, M., Rubin, E. H., Morris, J. C., Baty, J., Coats, M., Norton, J., Goate, A. M., et al. (1998) · Archives of Neurology · doi:10.1001/archneur.55.3.326 · Cited by 657 · see citing works

Functional Assessment Staging (FAST) in Alzheimer’s Disease: Reliability, Validity, and Ordinality

Sclan, S. G., & Reisberg, ‌. (1992) · International Psychogeriatrics · doi:10.1017/s1041610292001157 · Cited by 596 · see citing works

Clinico‐pathologic studies in dementia: Nondemented subjects with pathologically confirmed Alzheimer's disease

Crystal, H., Dickson, D., Fuld, P., Masur, D., Scott, R., Mehler, M., Masdeu, J., Kawas, C., Aronson, M., & Wolfson, L. (1988) · Neurology · doi:10.1212/wnl.38.11.1682 · Cited by 586 · see citing works

Prediction of probable Alzheimer's disease in memory-impaired patients

Tierney, M. C., Szalai, J. P., Snow, W. G., Fisher, R. H., Nores, A., Nadon, G., Dunn, E. M., & George‐Hyslop, P. S. (1996) · Neurology · doi:10.1212/wnl.46.3.661 · Cited by 575 · see citing works

Neurofibrillary Tangles, Amyloid, and Memory in Aging and Mild Cognitive Impairment

Guillozet-Bongaarts, A. L., Weıntraub, S., Mash, D. C., & Mesulam, M. M. (2003) · Archives of Neurology · doi:10.1001/archneur.60.5.729 · Cited by 572 · see citing works

Neurofibrillary tangles mediate the association of amyloid load with clinical Alzheimer disease and level of cognitive function

Bennett, D. A., Schneider, J. A., Wilson, R. S., Bienias, J. L., & Arnold, S. E. (2004) · Archives of Neurology · doi:10.1001/archneur.61.3.378 · Cited by 526 · see citing works

Neocortical Neurofibrillary Tangles Correlate With Dementia Severity in Alzheimer's Disease

Bierer, L. M., Hof, P. R., Purohit, D. P., Carlin, L., Schmeidler, J., Davis, K. L., & Perl, D. P. (1995) · Archives of Neurology · doi:10.1001/archneur.1995.00540250089017 · Cited by 514 · see citing works

Neuritic pathology and dementia in alzheimer's disease

McKee, A. C., Kosik, K. S., & Kowall, N. W. (1991) · Annals of Neurology · doi:10.1002/ana.410300206 · Cited by 358 · see citing works

β-amyloid deposition and other measures of neuropathology predict cognitive status in Alzheimer's disease

Cummings, B. J., Pike, C. J., Shankle, R., & Cotman, C. W. (1996) · Neurobiology of Aging · doi:10.1016/s0197-4580(96)00170-4 · Cited by 305 · see citing works

Image analysis of β-amyloid load in Alzheimer's disease and relation to dementia severity

Cummings, B. J., & Cotman, C. W. (1995) · The Lancet · doi:10.1016/s0140-6736(95)92053-6 · Cited by 260 · see citing works

Relationships between Regional Neuronal Loss and Neurofibrillary Changes in the Hippocampal Formation and Duration and Severity of Alzheimer Disease

BOBINSKI, M., WEGIEL, J., TARNAWSKI, M., BOBINSKI, M., REISBERG, B., DE LEON, M. J., MILLER, D. C., & WISNIEWSKI, H. M. (1997) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199704000-00010 · Cited by 208 · cited 1× · see citing works

Rates of progression in mild cognitive impairment and early Alzheimer’s disease

Storandt, M., Grant, E., Miller, J. P., & Morris, J. C. (2002) · Neurology · doi:10.1212/wnl.59.7.1034 · Cited by 203 · see citing works

Neurofibrillary tangles in nondemented elderly subjects and mild Alzheimer disease

Haroutunian, V., Purohit, D. P., Perl, D. P., Marin, D., Khan, K., Lantz, M., Davis, K. L., & Mohs, R. C. (1999) · Archives of Neurology · doi:10.1001/archneur.56.6.713 · Cited by 201 · see citing works

Atrophy of Hippocampal Formation Subdivisions Correlates with Stage and Duration of Alzheimer Disease

Bobinski, M., Węgiel, J., Wisniewski, H. M., Tarnawski, M. J., Mlodzik, B., Reisberg, ‌., de Leon, M. J., & Miller, D. C. (1995) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000106948 · Cited by 115 · see citing works

Stereologic assessment of the total cortical volume occupied by amyloid deposits and its relationship with cognitive status in aging and Alzheimer’s disease

Bussière, T., Friend, P. D., Sadeghi, N., Wicinski, B. A., Lin, G. I., Bouras, C., Giannakopoulos, P., Robakis, N. K. R. K., Morrison, J. H., Perl, D. P., et al. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00056-8 · Cited by 108 · see citing works

Cognitive impact of neuronal pathology in the entorhinal cortex and CA1 field in Alzheimer's disease

GUNTEN, A., KOVARI, E., BUSSIERE, T., RIVARA, C., GOLD, G., BOURAS, C., HOF, P., & GIANNAKOPOULOS, P. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.02.008 · Cited by 101 · see citing works

Dementia staging in chronic care populations.

Reisberg, ‌., Sclan, S. G., Franssen, E., Kluger, A., & Ferris, S. H. (1994) · PubMed · Cited by 90 · see citing works

Mild cognitive impairment and preclinical Alzheimer's disease.

Morris, J. C. (2005) · PubMed · Cited by 87 · see citing works

Progression of neurofibrillary changes and PHF-τ in end-stage Alzheimer’s disease is different from plaque and cortical microglial pathology

Thal, D. R., Arendt, T., Waldmann, G., Holzer, M., Zedlick, D., Rüb, U., & Schober, R. (1998) · Neurobiology of Aging · doi:10.1016/s0197-4580(98)00090-6 · Cited by 53 · see citing works

Reliability of Routine Clinical Instruments for the Assessment of Alzheimer's Disease Administered by Telephone

Monteiro, I. M., Boksay, I., Auer, S., Torossian, C. L., Sinaiko, E. A., & Reisberg, ‌. (1998) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/089198879801100105 · Cited by 45 · see citing works

The Stages of Alzheimer’s Disease: A Reappraisal

KRAEMER, H. C., Taylor, J. L., Tinklenberg, J. R., & Yesavage, J. A. (1998) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000017081 · Cited by 44 · see citing works

Staging methods for the assessment of dementia: Perspectives.

Cohen‐Mansfield, J., Reisberg, ‌., BONNEMA, J., Berg, L., Dastoor, D., PFEFFER, R. I., & Cohen, G. D. (1996) · PubMed · Cited by 33 · see citing works

Overview of Methodologie Issues for Pharmacologic Trials in Mild, Moderate, and Severe Alzheimer’s Disease

Reisberg, ‌., Franssen, E., Auer, S., Monteiro, I. M., Boksay, I., Shulman, E., Steinberg, G., Souren, L. E. M., Kluger, A., Torossian, C. L., et al. (1996) · International Psychogeriatrics · doi:10.1017/s1041610296002566 · Cited by 31 · see citing works

Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature

Nelson, P. T., Alafuzoff, I., Bigio, E. H., Bouras, C., Braak, H., Cairns, N. J., Castellani, R. J., Crain, B. J., Davies, P., Tredici, K. D., et al. (2012) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31825018f7 · Cited by 2,050 · see citing works

Using mice to model Alzheimer's dementia: an overview of the clinical disease and the preclinical behavioral changes in 10 mouse models

Webster, S. J., Bachstetter, A. D., Nelson, P. T., Schmitt, F. A., & Van Eldik, L. J. (2014) · Frontiers in Genetics · doi:10.3389/fgene.2014.00088 · Cited by 755 · see citing works

Working Memory and Executive Function Decline across Normal Aging, Mild Cognitive Impairment, and Alzheimer’s Disease

Kirova, A.-M., Bays, R. B., & Lagalwar, S. (2015) · BioMed Research International · doi:10.1155/2015/748212 · Cited by 649 · see citing works

Solid-State NMR Studies of Amyloid Fibril Structure

Tycko, R. (2011) · Annual Review of Physical Chemistry · doi:10.1146/annurev-physchem-032210-103539 · Cited by 548 · see citing works

The preclinical phase of the pathological process underlying sporadic Alzheimer’s disease

Braak, H., & Del Tredici, K. (2015) · Brain · doi:10.1093/brain/awv236 · Cited by 540 · see citing works

<scp>A</scp>rizona <scp>S</scp>tudy of <scp>A</scp>ging and <scp>N</scp>eurodegenerative <scp>D</scp>isorders and <scp>B</scp>rain and <scp>B</scp>ody <scp>D</scp>onation <scp>P</scp>rogram

Beach, T. G., Adler, C. H., Sue, L. I., Serrano, G., Shill, H. A., Walker, D. G., Lue, L., Roher, A. E., Dugger, B. N., Maarouf, C., et al. (2015) · Neuropathology · doi:10.1111/neup.12189 · Cited by 460 · see citing works

Clinicopathologic and¹¹C-Pittsburgh compound B implications of Thal amyloid phase across the Alzheimer’s disease spectrum

Murray, M. E., Lowe, V. J., Graff-Radford, N. R., Liesinger, A. M., Cannon, A., Przybelski, S. A., Rawal, B., Parisi, J. E., Petersen, R. C., Kantarci, K., et al. (2015) · Brain · doi:10.1093/brain/awv050 · Cited by 324 · see citing works

Widespread brain tau and its association with ageing, Braak stage and Alzheimer’s dementia

Lowe, V. J., Wiste, H. J., Senjem, M. L., Weigand, S. D., Therneau, T. M., Boeve, B. F., Josephs, K. A., Fang, P., Pandey, M. K., Murray, M. E., et al. (2017) · Brain · doi:10.1093/brain/awx320 · Cited by 302 · see citing works

Alzheimer Disease

Apostolova, L. G. (2016) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000000307 · Cited by 253 · see citing works

Tau-positron emission tomography correlates with neuropathology findings.

Lowe, V. J., Lundt, E. S., Albertson, S. M., Min, H., Fang, P., Przybelski, S. A., Senjem, M. L., Schwarz, C. G., Kantarci, K., Boeve, B., et al. (2020) · Alzheimer's &amp; Dementia · doi:10.1016/j.jalz.2019.09.079 · Cited by 203 · see citing works

Theta-Gamma Coupling and Working Memory in Alzheimer’s Dementia and Mild Cognitive Impairment

Goodman, M. S., Kumar, S., Zomorrodi, R., Ghazala, Z., Cheam, A., Barr, M. S., Daskalakis, Z. J., Blumberger, D. M., Fischer, C. E., Flint, A. J., et al. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00101 · Cited by 196 · see citing works

Dementia induces correlated reductions in white matter integrity and cortical thickness: A multivariate neuroimaging study with sparse canonical correlation analysis

Avants, B., Cook, P. A., Ungar, L., Gee, J. C., & Grossman, M. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2010.01.041 · Cited by 179 · see citing works

Staging of cognitive deficits and neuropathological and ultrastructural changes in streptozotocin-induced rat model of Alzheimer’s disease

Knezović, A., Barilar, J. O., Ćurlin, M., Hof, P. R., Šimić, G., Riederer, P. F., & Šalković‐Petrišić, M. (2015) · Journal of Neural Transmission · doi:10.1007/s00702-015-1394-4 · Cited by 145 · see citing works

Intraneuronal tau aggregation precedes diffuse plaque deposition, but amyloid-β changes occur before increases of tau in cerebrospinal fluid

Braak, H., Zetterberg, H., Tredici, K. D., & Blennow, K. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1139-0 · Cited by 141 · see citing works

Cross-sectional associations of tau-PET signal with cognition in cognitively unimpaired adults

Lowe, V. J., Bruinsma, T. J., Wiste, H. J., Min, H.-K., Weigand, S. D., Fang, P., Senjem, M. L., Therneau, T. M., Boeve, B. F., Josephs, K. A., et al. (2019) · Neurology · doi:10.1212/wnl.0000000000007728 · Cited by 107 · see citing works

Alzheimer's disease: Pathogenesis and prevention

Braak, H., & Tredici, K. D. (2012) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2012.01.011 · Cited by 103 · see citing works

Minocycline reduces inflammatory parameters in the brain structures and serum and reverses memory impairment caused by the administration of amyloid β (1-42) in mice

Garcez, M. L., Mina, F., Bellettini-Santos, T., Carneiro, F. G., Luz, A. P., Schiavo, G. L., Andrighetti, M. S., Scheid, M. G., Bolfe, R. P., & Budni, J. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.03.010 · Cited by 102 · see citing works

Combined treatment with the phenolics (−)-epigallocatechin-3-gallate and ferulic acid improves cognition and reduces Alzheimer-like pathology in mice

Mori, T., Koyama, N., Tan, J., Segawa, T., Maeda, M., & Town, T. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.004280 · Cited by 99 · see citing works

Neuroimaging correlates with neuropathologic schemes in neurodegenerative disease

Lowe, V. J., Lundt, E. S., Albertson, S. M., Przybelski, S. A., Senjem, M. L., Parisi, J. E., Kantarci, K., Boeve, B., Jones, D. T., Knopman, D., et al. (2019) · Alzheimer's &amp; Dementia · doi:10.1016/j.jalz.2019.03.016 · Cited by 90 · see citing works

High Degree of Heterogeneity in Alzheimer's Disease Progression Patterns

Komarova, N. L., & Thalhauser, C. J. (2011) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002251 · Cited by 92 · see citing works

Gallic acid is a dual α/β-secretase modulator that reverses cognitive impairment and remediates pathology in Alzheimer mice

Mori, T., Koyama, N., Yokoo, T., Segawa, T., Maeda, M., Sawmiller, D. R., Tan, J., & Town, T. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.012330 · Cited by 78 · see citing works

Cognition and Neuropathology in Aging: Multidimensional Perspectives from the Rush Religious Orders Study and Rush Memory and Aging Project

Negash, S., Bennett, D. A., Wilson, R. S., Schneider, J. A., & Arnold, S. E. (2011) · Current Alzheimer Research · doi:10.2174/156720511795745302 · Cited by 78 · see citing works

Comparison of memory, affective behavior, and neuropathology in APPNLGF knock-in mice to 5xFAD and APP/PS1 mice

Locci, A., Orellana, H., Rodríguez, G., Gottliebson, M., McClarty, B. M., Dominguez, S., Keszycki, R. M., & Dong, H. (2021) · Behavioural Brain Research · doi:10.1016/j.bbr.2021.113192 · Cited by 68 · see citing works

Sleep deficits in mild cognitive impairment are related to increased levels of plasma amyloid-β and cortical thinning

Sanchez-Espinosa, M. P., Atienza, M., & Cantero, J. L. (2014) · NeuroImage · doi:10.1016/j.neuroimage.2014.05.027 · Cited by 69 · see citing works

Is It Time to Rethink How Neuropsychological Tests Are Used to Diagnose Mild Forms of HIV-Associated Neurocognitive Disorders? Impact of False-Positive Rates on Prevalence and Power

Meyer, A.-C. L., Boscardin, W. J., Kwasa, J. K., & Price, R. W. (2013) · Neuroepidemiology · doi:10.1159/000354629 · Cited by 66 · see citing works

Mitochondrial Disturbances, Tryptophan Metabolites and Neurodegeneration: Medicinal Chemistry Aspects

Szalárdy, L., Klivènyi, P., Zádori, D., Fülöp, F., Toldi, J., & Vécsei, L. (2012) · Current Medicinal Chemistry · doi:10.2174/092986712800167365 · Cited by 60 · see citing works

Decoding perineuronal net glycan sulfation patterns in the Alzheimer's disease brain

Logsdon, A. F., Francis, K. L., Richardson, N. E., HU, S. J. W., Faber, C. L., Phan, B. A., Nguyen, V., Setthavongsack, N., Banks, W. A., Woltjer, R. L., et al. (2021) · Alzheimer s & Dementia · doi:10.1002/alz.12451 · Cited by 55 · see citing works

Hsp90 co-chaperones, FKBP52 and Aha1, promote tau pathogenesis in aged wild-type mice

Criado‐Marrero, M., Gebru, N. T., Blazier, D. M., Gould, L. A., Baker, J. D., Beaulieu‐Abdelahad, D., & Blair, L. J. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01159-w · Cited by 51 · see citing works

Evolutional Aspects of Alzheimer's Disease Pathogenesis

Braak, H., & Tredici, K. D. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-129029 · Cited by 51 · see citing works

High avidity HSV-1 antibodies correlate with absence of amnestic Mild Cognitive Impairment conversion to Alzheimer’s disease

Agostini, S., Mancuso, R., Baglio, F., Cabinio, M., Hernis, A., Costa, A. S., Calabrese, E., Nemni, R., & Clerici, M. (2016) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2016.07.153 · Cited by 50 · see citing works

Tau phosphorylation in human brain: relationship to behavioral disturbance in dementia

Guadagna, S., Esiri, M. M., Williams, R. J., & Francis, P. T. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.01.015 · Cited by 48 · see citing works

A Novel Therapeutic Approach to Treat Alzheimer’s Disease by Neurotrophic Support During the Period of Synaptic Compensation

Baazaoui, N., & Iqbal, K. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-170839 · Cited by 43 · see citing works

Mild Cognitive Impairment, Slow Gait, and Risk of Disability: A Prospective Study

Doi, T., Shimada, H., Makizako, H., Tsutsumimoto, K., Hotta, R., Nakakubo, S., & Suzuki, T. (2015) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2015.07.007 · Cited by 42 · see citing works

Brain controllability distinctiveness between depression and cognitive impairment

Fang, F. Z., Gao, Y., Schulz, P. E., Selvaraj, S., & Zhang, Y. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.07.106 · Cited by 42 · see citing works

Neurochemical Profile of Dementia Pugilistica

Kokjohn, T. A., Maarouf, C. L., Daugs, I. D., Hunter, J. M., Whiteside, C. M., Malek-Ahmadi, M., Rodriguez, E., Kalback, W., Jacobson, S. A., Sabbagh, M. N., et al. (2013) · Journal of Neurotrauma · doi:10.1089/neu.2012.2699 · Cited by 39 · see citing works

Neuropathological Changes in Aging Brain

Xekardaki, A., Kövari, E., Gold, G., Papadimitropoulou, A., Giacobini, E., Herrmann, F. R., Giannakopoulos, P., & Bouras, C. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-08939-3_6 · Cited by 34 · see citing works

Bapineuzumab Alters Aβ Composition: Implications for the Amyloid Cascade Hypothesis and Anti-Amyloid Immunotherapy

Roher, A. E., Cribbs, D. H., Kim, R. C., Maarouf, C. L., Whiteside, C. M., Kokjohn, T. A., Daugs, I. D., Head, E., Liebsack, C., Serrano, G. E., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059735 · Cited by 34 · see citing works

Pathological Correlates of Cognitive Impairment in The University of Manchester Longitudinal Study of Cognition in Normal Healthy Old Age

Robinson, A., Davidson, Y. S., Horan, M. A., Pendleton, N., & Mann, D. M. A. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180171 · Cited by 29 · see citing works

Alzheimer’s Disease Progressively Reduces Visual Functional Network Connectivity

Huang, J., Beach, P. A., Bozoki, A., & Zhu, D. C. (2021) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-210017 · Cited by 31 · see citing works

Elevated medial temporal lobe and pervasive brain tau‐PET signal in normal participants

Lowe, V. J., Bruinsma, T. J., Min, H.-K. P., Lundt, E. S., Fang, P., Senjem, M. L., Boeve, B. F., Josephs, K. A., Pandey, M. K., Murray, M. E., et al. (2018) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2018.01.005 · Cited by 30 · see citing works

Antidepressant agomelatine attenuates behavioral deficits and concomitant pathology observed in streptozotocin-induced model of Alzheimer's disease in male rats

Ilieva, K., Tchekalarova, J. D., Atanasova, D., Kortenska, L., & Atanasova, M. (2018) · Hormones and Behavior · doi:10.1016/j.yhbeh.2018.11.007 · Cited by 29 · see citing works

Parkin prevents cortical atrophy and Aβ-induced alterations of brain metabolism: 13C NMR and magnetic resonance imaging studies in AD models

Algarzae, N. K., Hebron, M. L., Miessau, M., & Moussa, C. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.08.057 · Cited by 27 · see citing works

Predicting functional decline in aging and Alzheimer’s disease with PET-based Braak staging

Macedo, A. C., Therriault, J., Tissot, C., Arias, J. F., Ferreira, P. C. L., Vitali, P., Servaes, S., Rahmouni, N., Vermeiren, M. R., Bezgin, G., et al. (2024) · Brain Communications · doi:10.1093/braincomms/fcae043 · Cited by 24 · see citing works

The Progressive Supranuclear Palsy: Past and Present Aspects

Parthimos, T. P., & Schulpis, K. H. (2019) · Clinical Gerontologist · doi:10.1080/07317115.2019.1694115 · Cited by 24 · see citing works

The Comparison of Cognitive and Functional Performance in Children and Alzheimer's Disease Supports the Retrogenesis Model

Rubial-Álvarez, S., de Sola, S., Machado, M.-C., Sintas, E., Böhm, P., Sánchez‐Benavides, G., Langohr, K., Múñiz, R., & Peña‐Casanova, J. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-121123 · Cited by 23 · see citing works

The “LEARn” (Latent Early-Life Associated Regulation) Model: An Epigenetic Pathway Linking Metabolic and Cognitive Disorders

Lahiri, D. K., & Maloney, B. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-120373 · Cited by 21 · see citing works

Souvenaid®: A new approach to management of early Alzheimer's disease

Ritchie, C. W., Bajwa, J., Coleman, G., Hope, K. W., Jones, R. W., Lawton, M., Marven, M., & Passmore, P. (2013) · The journal of nutrition health & aging · doi:10.1007/s12603-013-0411-2 · Cited by 20 · see citing works

Amnestic Mild Cognitive Impairment and Conversion to Alzheimer's Disease: Insulin Resistance and Glycoxidation as Early Biomarker Clusters

Monacelli, F., Borghi, R., Cammarata, S., Nencioni, A., Piccini, A., Tabaton, M., & Odetti, P. R. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-142511 · Cited by 18 · see citing works

Neuropsychological Performance Is Correlated With Tau Protein Deposition and Glucose Metabolism in Patients With Alzheimer’s Disease

Qiao, Z., Wang, G., Zhao, X. B., Wang, K., Fan, D., Chen, Q., & Ai, L. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.841942 · Cited by 15 · see citing works

Quantitative Appraisal of Ventricular Cerebrospinal Fluid Biomarkers in Neuropathologically Diagnosed Parkinson's Disease Cases Lacking Alzheimer's Disease Pathology

Maarouf, C. L., Beach, T. G., Adler, C. H., Malek‐Ahmadi, M. H., Kokjohn, T. A., Dugger, B. N., Walker, D. G., Shill, H. A., Jacobson, S. A., Sabbagh, M. N., et al. (2013) · Biomarker Insights · doi:10.4137/bmi.s11422 · Cited by 15 · see citing works

Top-Down Projections Direct the Gradual Progression of Alzheimer-Related Tau Pathology Throughout the Neocortex

Braak, H., & Tredici, K. D. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-32-9358-8_22 · Cited by 10 · see citing works

The Global Deterioration Scale for Down Syndrome Population (GDS-DS): A Rating Scale to Assess the Progression of Alzheimer’s Disease

Rodriguez, E., García‐Alba, J., Novell, R., & Esteba‐Castillo, S. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20065096 · Cited by 11 · see citing works

Scores Obtained from a Simple Cognitive Test of Visuospatial Episodic Memory Performed Decades before Death Are Associated with the Ultimate Presence of Alzheimer Disease Pathology

Robinson, A., McNamee, R., Davidson, Y. S., Horan, M. A., Snowden, J. S., McInnes, L., Pendleton, N., & Mann, D. M. A. (2018) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000486827 · Cited by 11 · see citing works

Genetic influences on cognition in progressive supranuclear palsy

Gerstenecker, A. T., Roberson, E. D., Schellenberg, G. D., Standaert, D. G., Shprecher, D., Kluger, B. M., & Litvan, I. (2017) · Movement Disorders · doi:10.1002/mds.27196 · Cited by 11 · see citing works

Antibodies to Multiple Receptors are Associated with Neuropsychiatric Symptoms and Mortality in Alzheimer’s Disease: A Longitudinal Study

Giil, L. M., Aarsland, D., Hellton, K. H., Lund, A., Heidecke, H., Schulze‐Forster, K., Riemekasten, G., Vik‐Mo, A. O., Kristoffersen, E. K., Vedeler, C. A., et al. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-170882 · Cited by 10 · see citing works

Depression and the Diagnosis of MCI in a Culturally Diverse Sample in the United States

Lang, M. K., Rosselli, M., Greig, M. T., Torres, V. L., Vélez-Uribe, I., Arruda, F., Barker, W., Garcia, P., Loewenstein, D., Curiel, R. E., et al. (2019) · Archives of Clinical Neuropsychology · doi:10.1093/arclin/acz043 · Cited by 10 · see citing works

[Pathogenesis and prevention of Alzheimer's disease: when and in what way does the pathological process begin?].

Braak, H., Feldengut, S., & Tredici, K. D. (2013) · Der Nervenarzt · doi:10.1007/s00115-012-3688-1 · Cited by 5 · see citing works

Association of Alzheimer’s Disease and Other Neuropathologies With Functional Disability in Persons With and Without Dementia

Farfel, J. M., Capuano, A. W., Buchman, A. S., Schneider, J. A., & Bennett, D. A. (2024) · The Journals of Gerontology Series A · doi:10.1093/gerona/glae118 · Cited by 7 · see citing works

Validation of brief cognitive tests in mild cognitive impairment, Alzheimer's disease and dementia with Lewy bodies.

Palmqvist, S. (2011) · Lund University Publications (Lund University) · Cited by 7 · see citing works

Telephone Interview for Cognitive Status Scores Associate with Cognitive Impairment and Alzheimer’s Disease Pathology at Death

Robinson, A., Davidson, Y. S., Roncaroli, F., Minshull, J., Tinkler, P., Cairns, M., Horan, M. A., Payton, A., & Mann, D. M. A. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-215102 · Cited by 6 · see citing works

Alzheimer's Disease, Neural Basis of

Braak, H., & Tredici-Braak, K. D. (2015) · Elsevier eBooks · doi:10.1016/b978-0-08-097086-8.55001-6 · Cited by 6 · see citing works

Targeting apolipoprotein E and N-terminal amyloid β-protein precursor interaction improves cognition and reduces amyloid pathology in Alzheimer’s mice

Sawmiller, D. R., Koyama, N., Fujiwara, M., Segawa, T., Maeda, M., & Mori, T. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.104846 · Cited by 5 · see citing works

Neurocognitive Engagement Therapy

Howanitz, J., Carney, K. O., Lichtenberg, P. A., Donlan, A., Sugarman, M. A., & Malek, K. (2018) · Topics in Geriatric Rehabilitation · doi:10.1097/tgr.0000000000000172 · Cited by 4 · see citing works

The Pattern of Lesions During the Transition to the Symptomatic Phase and in Fully Developed Alzheimer’s Disease

Braak, H., & Tredici, K. D. (2014) · Advances in anatomy, embryology and cell biology · doi:10.1007/978-3-319-12679-1_9 · Cited by 3 · see citing works

Alzheimer's Disease Protein Targets: Comprehensive Review and Future Directions

Kumar, B. S. H., Dinesh, B. G. H., Shajan, S. R. O., Sadashivappa, N. M., Ammunje, D. N., Kunjiappan, S., Theivendren, P., & Pavadai, P. (2024) · Current Pharmaceutical Design · doi:10.2174/0113816128334916241006195142 · Cited by 3 · see citing works

Development and characterization of nanostructured lipid carriers for sustained rivastigmine delivery in Alzheimer's disease

Assaf, S. M., Almnayyes, A. I., Obaidat, R., & Maaroof, K. T. (2025) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2025.107803 · Cited by 2 · see citing works

Neurodegenerative changes in the brainstem and olfactory bulb in people older than 50 years old: a descriptive study

de Oliveira, F. H., Neto, E. R., Fonseca, M. K., Costa, A. S. R., Rockenbach, M. A. B. C., Padilha, R. D. S., Fernandez, L. L., & Hilbig, A. (2015) · Arquivos de Neuro-Psiquiatria · doi:10.1590/0004-282x20150066 · Cited by 2 · see citing works

Gut Microbiota, a Key Factor Relating Diet and Inflammation with the Progression of Cognitive Impairment in Older People

Pérez‐Martínez, G. (2017) · Journal of Nutritional Health & Food Engineering · doi:10.15406/jnhfe.2017.06.00192 · Cited by 2 · see citing works

Clinical Meaningfulness of Biomarker Endpoints in Alzheimer’s Disease Research

Ng, K. P., Pascoal, T. A., Li, X., Rosa‐Neto, P., & Gauthier, S. G. (2018) · Neuromethods · doi:10.1007/978-1-4939-7674-4_16 · Cited by 2 · see citing works

An Overview on Dementia: A Major Symptom of Alzheimer's Disease

Kaur, J., Melkani, I., Singh, A., Singh, A. P., & Bala, K. (2022) · Journal of Drug Delivery and Therapeutics · doi:10.22270/jddt.v12i4.5445 · Cited by 1 · see citing works

Comparing Gallyas and AT8 staining for quantification of tau pathology in subregions of the human hippocampus

Breningstall, B. M., Abdollahi, E., Hawes, D., Hiniker, A. O., & Bienkowski, M. S. (2025) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlaf149 · Cited by 1 · see citing works

Quantification of Alzheimer DiseaseAmyloid β Peptide 43 in Human BrainWith a Newly Developed Enzyme-LinkedImmunosorbent Assay (ELISA)

Nicklagård, E. (2011) · DiVA (Linkoping University)

Development and Characterization of Nanostructured Lipid Carriers for Sustained Rivastigmine DeliveryPreprint

Assaf, S. M., Almnayyes, A. I., & Obaidat, R. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5379254

Additional file 1 of Hsp90 co-chaperones, FKBP52 and Aha1, promote tau pathogenesis in aged wild-type mice

Criado‐Marrero, M., Gebru, N. T., Blazier, D. M., Gould, L. A., Baker, J. D., Beaulieu‐Abdelahad, D., & Blair, L. J. (2021) · Figshare · doi:10.6084/m9.figshare.14391487

Functional Disability and MMPs in Alzheimer’s Disease

Alkanlı, N., Alkanlı, S. S., & Ay, A. (2025) · Springer eBooks · doi:10.1007/978-3-031-40858-8_565-1

Pregnancy and breastfeeding are associated with less later‐life cognitive decline in a longitudinal, prospective cohort

Fox, M. M., Bramen, J. E., Kwon, D., Espeland, M. A., Sun, Y., Zhang, L., Shadyab, A. H., Casanova, R., Manson, J. E., Chang, M. Y., et al. (2026) · Alzheimer s & Dementia · doi:10.1002/alz.71072

Intégrité de la barrière hémato-encéphalique et transport du peptide bêta-amyloïde dans la maladie d'Alzheimer

Do, T. M. (2012) · theses.fr (ABES) · doi:10.70675/39078922z7524z4044z80dcz166165217d2b

Les nanotubes comme nouvelle voie de transfert et de propagation de la protéine Tau pathologique

Tardivel, M. (2017) · theses.fr (ABES) · doi:10.70675/0cfcd049z970ez4f2dz8417z195cfabdc00d

Functional Disability and MMPs in Alzheimer’s Disease

Alkanlı, N., Alkanlı, S. S., & Ay, A. (2026) · Springer eBooks · doi:10.1007/978-3-032-11375-7_565

Pathological correlates of cognitive decline in Alzheimer's disease.

Thind, K., & Sabbagh, M. N. (2007) · PubMed · Cited by 18 · see citing works

β-amyloid deposition and other measures of neuropathology predict cognitive status in Alzheimer's disease

Cummings, B. J., Pike, C. J., Shankle, R., & Cotman, C. W. (1996) · Neurobiology of Aging · doi:10.1016/s0197-4580(96)00170-4 · Cited by 305 · see citing works

Clinicopathologic Correlations in a Large Alzheimer Disease Center Autopsy Cohort: Neuritic Plaques and Neurofibrillary Tangles "Do Count" When Staging Disease Severity

Nelson, P. T., Jicha, G. A., Schmitt, F. A., Liu, H., Davis, D. G., Mendiondo, M. S., Abner, E. L., & Markesbery, W. R. (2007) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/nen.0b013e31815c5efb · Cited by 292 · see citing works

O3‐07‐04: Neuropathologic correlates of trial‐related clinical assessments

Cummings, J. L., & Lee, C. (2010) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2010.05.438

Correlations between mental state and quantitative neuropathology in the Vienna Longitudinal Study on Dementia

Bancher, C., Jellinger, K., Lassmann, H., Fischer, P., & Leblhuber, F. (1996) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/bf02189115 · Cited by 130 · see citing works